These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4061540)

  • 1. Effect of hydatidiform molar vesicular fluid on blood coagulation.
    Kaplan SS; Szulman AE; Surti U
    Am J Obstet Gynecol; 1985 Nov; 153(6):703-7. PubMed ID: 4061540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
    Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
    BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decidual T lymphocyte activation in hydatidiform mole.
    Wongweragiat S; Searle RF; Bulmer JN
    J Clin Pathol; 1999 Dec; 52(12):888-94. PubMed ID: 10711251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Procoagulant properties of the amniotic fluid I. Thromboplastin acceleration time in amniotic fluid throughout normal pregnancies. Its clinical perspectives].
    Angeles Weintraub CD; Villalobos Román M; Valdés Macho JE; Chávez Azuela J; Máximo Luviano O
    Ginecol Obstet Mex; 1986 Oct; 54():260-4. PubMed ID: 3792882
    [No Abstract]   [Full Text] [Related]  

  • 5. Thromboplastic and fibrinolytic activity of hydatidiform molar tissue and vesicular fluid.
    Tsakok FH; Ratnam SS; Chew SC; Chua SE
    Br J Obstet Gynaecol; 1979 Mar; 86(3):233-7. PubMed ID: 218607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation and fibrinolysis in intact hydatidiform molar pregnancy.
    Tsakok FH; Koh S; Ratnam SS
    Br Med J; 1976 Dec; 2(6050):1481-4. PubMed ID: 1000261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles.
    Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA
    Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation and fibrinolysis in molar pregnancy.
    López-Llera M; de la Luz Espinosa M; Ramos JN; de León MD
    Am J Obstet Gynecol; 1977 Apr; 127(8):855-60. PubMed ID: 851143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Fas/Fas ligand by decidual leukocytes in hydatidiform mole.
    Wongweragiat S; Searle RF; Bulmer JN
    Biol Reprod; 2001 Mar; 64(3):784-9. PubMed ID: 11207192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic and immunohistochemical evaluation of blood vessels in complete and partial hydatidiform mole.
    Dickson-González SM; García de Barriola V; Barbella-Aponte RA; Figueira L; Cortés-Charry R; Naranjo de Gómez M
    J Reprod Med; 2006 Dec; 51(12):933-7. PubMed ID: 17253040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive complete and partial hydatidiform mole.
    Rice LW; Lage JM; Berkowitz RS; Goldstein DP; Bernstein MR
    Obstet Gynecol; 1989 Aug; 74(2):217-9. PubMed ID: 2748058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired coagulation defects of pregnancy--including a case of a patient with hydatidiform mole.
    TALBERT LM; EASTERLING WE; FLOWERS CE; GRAHAM JB
    Obstet Gynecol; 1961 Jul; 18():69-76. PubMed ID: 13775019
    [No Abstract]   [Full Text] [Related]  

  • 13. [Expression of p57 marker in differential diagnosis of complete and partial mole - correlation with DNA analysis].
    Cierna Z; Palkovič M; Danihel Ml L; Danihel L; Repiská V; Vojtaššák J; Korbeľ M
    Cesk Patol; 2012 Oct; 48(4):218-21. PubMed ID: 23121032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2--Genetics.
    Fisher RA; Paradinas FJ; Soteriou BA; Foskett M; Newlands ES
    J Pathol; 1997 Feb; 181(2):189-95. PubMed ID: 9120724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time.
    Burns ER; Goldberg SN; Wenz B
    Am J Clin Pathol; 1993 Aug; 100(2):94-8. PubMed ID: 8356955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental expression of VEGF is increased in pregnancies with hydatidiform mole: possible association with developing very early onset preeclampsia.
    Zhao M; Yin Y; Guo F; Wang J; Wang K; Chen Q
    Early Hum Dev; 2013 Aug; 89(8):583-8. PubMed ID: 23522390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procoagulant properties of amniotic fluid.
    Phillips LL; Davidson EC
    Am J Obstet Gynecol; 1972 Aug; 113(7):911-9. PubMed ID: 4635740
    [No Abstract]   [Full Text] [Related]  

  • 19. Properties of optical data from activated partial thromboplastin time and prothrombin time assays.
    Braun PJ; Givens TB; Stead AG; Beck LR; Gooch SA; Swan RJ; Fischer TJ
    Thromb Haemost; 1997 Sep; 78(3):1079-87. PubMed ID: 9308757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decidual immune cell infiltrate in hydatidiform mole.
    Hussein MR; Abd-Elwahed AR; Abodeif ES; Abdulwahed SR
    Cancer Invest; 2009 Jan; 27(1):60-6. PubMed ID: 19160109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.